Skip to main content
. Author manuscript; available in PMC: 2017 Nov 27.
Published in final edited form as: Pediatr Blood Cancer. 2016 Oct 27;64(4):10.1002/pbc.26278. doi: 10.1002/pbc.26278

TABLE 2.

Four-year EFS for stage by CHIPS

CHIPS N Stage I Stage 2 Stage 3 Stage 4 Entire cohort
0 341 94.7 ± 3.7 (N = 41) 93.0 ± 2.0 (N = 185) 91.1 ± 2.9 (N = 115) (N = 0) 93.1 ± 1.4 NSS
1 405 91.7 ± 8.0 (N = 14) 88.7 ± 2.0 (N = 251) 88.1 ± 4.2 (N = 63) 87.8 ± 3.8 (N = 77) 88.5 ± 1.6 NSS
2 217 80.0 ± 17.9 (N = 5) 78.6 ± 3.7 (N = 129) 80 + 8.9 (N = 20) 74.5 ± 5.7 (N = 63) 77.6 ± 2.9 NSS
3 55 100 (N = 2) 64.5 ± 9.6 (N = 27) (N = 0) 72.7 ± 8.8 (N = 26) 69.2 ± 6.5 NSS
Total 1018 P < 0.001